Abstract
Interferon is beneficial in some patients with chronic hepatitis C. To assess the efficacy of interferon, we used the polymerase chain reaction (PCR) to measure HCV RNA in serial serum samples from 13 chronic hepatitis C patients who were treated with interferon-α. Serum alanine aminotransferase (ALT) values normalized in association with the disappearance of serum HCV RNA in nine cases during the therapy. Serum HCV remained negative after the therapy in the three patients who had no, relapse, while serum HCV RNA reappeared in the six patients with elevation of ALT values. The persistence of normal ALT levels appears to be correlated with the clearance of the serum HCV. There were two patients whose ALT became normal immediately after the cessation of interferon. Serum HCV was detectable at the end of treatment when serum ALT was elevated, and thereafter serum HCV disappeared. This result, suggests an immunomodulatory effect of interferon in the clearance of HCV in some cases. Furthermore, the semiquantitative PCR assay showed that all five patients in whom ALT values were normal at the end of follow-up without detectable serum HCV genome had lower HCV titers in the pretreatment sera than the other eight patients. The detection of HCV RNA by the PCR assay is useful in determining the efficacy of interferon and its mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364, 1989
Dienstag JL: Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85:439–462, 1983
Koretz RL, Stone O, Mousa M, Gitnick GL: Non-A, non-B posttransfusion hepatitis—a decade later. Gastroenterology 88:1251–1254, 1985
Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer Jr HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro CF, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, the Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 321:1501–1506, 1989
Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH: Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506–1510, 1989
Shindo M, Di Bisceglie AM, Cheung L Shih W-K, Cristiano K, Feinstone SM, Hoofnagle JH: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 115:700–704, 1991
De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uehlinger E, Wepler W: A classification of chronic hepatitis. Lancet 2:626–628, 1968
Fukuda S, Ando S, Sanou O, Taniai M, Fujii M, Masaki N, Nakamura K, Ando O, Torigoe K, Sugimoto T, Kurimoto M: Simultaneous production of natural human tumor necrosis factor-α, −β and interferon-α from BALL-1 cells stimulated by HVJ. Lymphokine Res 7:175–185, 1988
Shibata M, Morishima T, Kudo T, Maki T, Maki S, Nagai Y: Serum hepatitis C virus sequences in post-transfusion non-A, non-B hepatitis. Blood 77:1157–1160, 1991
Kwok S, Higuchi R: Avoiding false positives with PCR. Nature 339:237–238, 1989
Dusheiko GM, Di Bisceglie A, Bowyer S, Sacks E, Kew MC: Prolonged recombinant leukocyte interferon treatment of chronic hepatitis B. Hepatology 5:556–560, 1985
Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Hallahan C, Park Y, Meschievitz C, Jones EA: Randomized, controlled trial of recombinant human alfa-interferon in patients with chronic hepatitis B. Gastroenterology 95:1318–1325, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shibata, M., Kumada, T., Yamada, M. et al. Effects of interferon-α on serum hepatitis C virus in patients with chronic hepatitis C. Digest Dis Sci 38, 608–611 (1993). https://doi.org/10.1007/BF01316788
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316788